Man Revives After Freezing Overnight

For Sissy Smith, it was nothing less than a miracle, when she learnt that her son, Justin, has revived after being frozen for an entire night in subzero temperatures. The 26-year-old was about to be declared dead when he regained consciousness. The incident took place in February 2015. While, walking back towards home after a night out with friends at a bar, Justin Smith, was likely to have slipped and subsequently hit his head before falling onto a snowbank. Estimations had to be made by the doctors because Justin cannot remember anything.

Curious query in US: When should women stop with mammograms?

A lot of debate is going on in various circles in the US about when women should start with mammograms: at the age of 40 or 50. But there is hardly any discussion on what should be the age to discontinue the precautionary practice against breast cancer, especially when a majority of the American population falls under the aged category.

Last week, the United States Preventive Services Task Force (USPSTF), through its draft breast cancer screening guidelines, suggested increasing the starting mammogram age of women from 40 to 50 years. In the process, the USPSTF chose to ignore the American Cancer Society’s claims that about 25% of women who die of breast cancer were diagnosed in their 40s.

Recent Study Bewares Melanoma Patients with Pregnancy

If a woman is diagnosed with Melanoma, a skin cancer, during pregnancy, it’s a sign that there is an immediate need to visit dermatologist. Even a patient of Melanoma would find his disease intensifying rapidly, if chooses to go pregnant. The finding was published, as a warning, online in the Journal of the American Academy of Dermatology on January 20.

The study was carried out by Dr. Brian Gastman, a plastic surgeon at Cleveland Clinic and author of the study on 462 women diagnosed with Melanoma between 1988 and 2012.The women aged 49 or younger. The researchers studied the participants’ health for more than two years. The study, aimed to find connection between Melanoma and pregnancy, found that women suffering from Melanoma during pregnancy were at more risk than others.

Increasing Healthy Fats Equally Important To Avoid Heart Risk

Health experts have always advised to avoid the consumption of unhealthy fats that are present in red meat and dairy products in an effort to maintain health of our hearts. Animal fats are likely to stick to the walls of our heart vessels that can result in plagues, leading to heart attacks, strokes and various heart-related issues. However, a new study has revealed that an increase in the consumption of healthy fats is equally important to avoid heart diseases. The research involved the compilation of studies associated with dietary information of 3.8 billion people in 186 countries.

Beloranib’s Phase 3 Trial Successful

The biopharmaceutical company Zafgen has announced the successful completion of the phase 3 trial of its treatment for an unusual genetic obesity disorder, known as Prader-Willi syndrome. The success comes after the trial of the treatment previously resulted in two deaths.

The Boston-based company’s beloranib has shown effectiveness in reducing weight of people suffering from this syndrome, which results in critical obesity due to intolerable hunger.

Duchenne Muscular Dystrophy Treatment Makes Little Progress

Hopes are apparently dying that the drug industry will be able to quickly come up with a treatment for an inherited muscle-wasting disorder, known as Duchenne muscular dystrophy, one of the most eagerly researched diseases of recent years.

Progress in understanding the disease triggered a research-and- development bang lately, fueling excitement that pushed the stock prices of some small companies. There are probably 28 trials or studies for potential therapies, which involve a drug for Duchenne or closely linked Becker muscular dystrophy. There are many companies working in the area, including Pfizer Inc. and PTC Therapeutics.

Pages

News in Focus

Mahindra & Mahindra Share Price Target at Rs 4,100 as Plan Execution Remains Strong: ICICI Securities

ICICI Securities has maintained a Buy rating on Mahindra & Mahindra, raising its target price to Rs 4,100 from Rs 4,000, implying 25% upside from the current market price of Rs 3,284.

Home First Finance Share Price Target at Rs 1,400: IDBI Capital

IDBI Capital has reiterated a Buy rating on Home First Finance Company, setting a target price of Rs 1,400, implying 19% upside from the current market price of Rs 1,181.

Suzlon Energy Share Price Target at Rs 65: ICICI Direct

ICICI Securities has maintained a Buy rating on Suzlon Energy, retaining an unchanged target price of Rs 65, implying 35% upside from the current market price of Rs 48.

Tata Power Share Price Target at Rs 485: ICICI Securities

ICICI Securities has reiterated a Buy rating on Tata Power Company, maintaining a target price of Rs 485, implying 31% upside from the current market price of Rs 371.

CoForge Limited Share Price Target at Rs 1,950: ICICI Securities

ICICI Securities has maintained a Buy rating on Coforge Limited, setting a target price of Rs 1,950, implying a 17% upside from the current market price of Rs 1,669.

Bharat Electronics Share Price Could Reach Rs 530: ICICI Securities Remains Bullish on PSU Major

ICICI Securities has maintained a Buy rating on Bharat Electronics, setting a target price of Rs 530, implying a 35% upside from the current market price of Rs 394.